pyrroles has been researched along with Alopecia Cicatrisata in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (4.76) | 29.6817 |
2010's | 25 (59.52) | 24.3611 |
2020's | 15 (35.71) | 2.80 |
Authors | Studies |
---|---|
AlAnazi, R; AlHarithy, R; AlHayaza, G; AlIssa, A; AlKhalifah, A; AlMarzoug, A; AlOrainy, M; AlSheikh, A; AlTawil, L | 1 |
Dunnick, CA; Kibbie, J; Kines, K; Norris, D | 1 |
Benton, S; Farah, R; Freese, R; Hordinsky, M | 1 |
Albayda, J; Castillo, R | 1 |
Bordone, LA; Fan, W; Lavian, J; Lee, EY; Youssef, S | 1 |
Arias-Santiago, S; Cantudo-Cuenca, MR; Diaz-Calvillo, P; Molina-Leyva, A; Rodriguez-Pozo, JA; Sanchez-Diaz, M; Tercedor-Sánchez, J | 1 |
Geng, SL; Gong, T; Ji, C; Su, HH | 1 |
Abdulla, N; Al-Obaidli, A; Ali-Alam, M; Husein-ElAhmed, H; Steinhoff, M | 1 |
Akdogan, N; Atakan, N; Doğan, S; Ersoy-Evans, S | 1 |
Jerjen, R; Meah, N; Sinclair, R; Trindade de Carvalho, L; Wall, D | 1 |
Lomborg, N; Lottenburger, T | 1 |
Maksimow, A; Stintzing, D; Wohlrab, J | 1 |
Dincer, D; Kose Ozkan, C; Tanacan, E | 1 |
Kamath, S | 1 |
Castelo-Soccio, L; McKenzie, PL | 1 |
Bhoyrul, B; Kerkemeyer, KLS; Sinclair, RD | 1 |
Castelo-Soccio, L | 1 |
Kim, BY; Kim, HS | 1 |
Avila, L; Lo Sicco, K; Shapiro, J; Strazzulla, LC | 1 |
Adışen, E; Aksakal, AB; Erduran, F | 1 |
Deenonpoe, R; Meephansan, J; Ponnikorn, S; Suchonwanit, P; Thummakriengkrai, J; Yingmema, W | 1 |
Pandey, M; Ramasamy, M; Shukla, M | 1 |
Castelo-Soccio, L; Putterman, E | 1 |
Bokhari, L; Sinclair, R | 1 |
Bordone, LA; Christiano, AM; Khanna, T; Sallee, B; Yang, CC | 1 |
Cho, S; Huh, CH; Kim, MW; Kwon, O; Lee, JS; Park, HS; Shin, JW | 1 |
Almutairi, N; Hussain, NH; Nour, TM | 1 |
Chen, CC; Dai, YX | 1 |
Cuenca-Barrales, C; Linares-Gonzalez, L; Ródenas-Herranz, T; Ruiz-Villaverde, R | 1 |
Santos, LDN; Shapiro, J | 1 |
Cranwell, WC; De Cruz, R; Doolan, BJ; Varigos, GA | 1 |
Craiglow, BG; King, BA | 1 |
Mirmirani, P | 1 |
Dhayalan, A; King, BA | 1 |
Abramovits, W; Carviel, JL; Gupta, AK | 1 |
Gerdes, S; Gläser, R; Mrowietz, U; Schröder, O | 1 |
Craiglow, BG; King, BA; Liu, LY | 1 |
Craiglow, BG; Dai, F; King, BA; Liu, LY | 1 |
Ferreira, SB; Scheinberg, M | 1 |
Ferreira, R; Ferreira, SB; Jaller, AM; Jaller, JA; Jaller, JJ; Jaller-Char, JJ; Scheinberg, M | 1 |
Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC | 1 |
Segal, AS | 1 |
1 review(s) available for pyrroles and Alopecia Cicatrisata
Article | Year |
---|---|
What's New in Hair Loss.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Alopecia Areata; Azetidines; Humans; Janus Kinase Inhibitors; Nitriles; Piperidines; Platelet-Rich Plasma; Purines; Pyrazoles; Pyrimidines; Pyrroles; Retinoids; Sulfonamides | 2019 |
2 trial(s) available for pyrroles and Alopecia Cicatrisata
Article | Year |
---|---|
Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
Topics: Administration, Cutaneous; Alopecia; Clobetasol; Double-Blind Method; Glucocorticoids; Hair; Humans; Janus Kinase Inhibitors; Nitriles; Ointments; Pilot Projects; Piperidines; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles | 2018 |
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Hair; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Time Factors; Young Adult | 2019 |
39 other study(ies) available for pyrroles and Alopecia Cicatrisata
Article | Year |
---|---|
Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.
Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Saudi Arabia; Treatment Outcome | 2022 |
Oral tofacitinib for the treatment of alopecia areata in pediatric patients.
Topics: Adolescent; Alopecia; Alopecia Areata; Child; Female; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome | 2022 |
Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.
Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies | 2022 |
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib.
Topics: Adult; Alopecia; Alopecia Areata; Dermatomyositis; Female; Humans; Interferons; Piperidines; Pyrimidines; Pyrroles | 2022 |
Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection.
Topics: Alopecia; Alopecia Areata; COVID-19; Humans; Piperidines; Pyrroles | 2023 |
Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response.
Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles | 2022 |
Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children.
Topics: Alopecia; Alopecia Areata; Child, Preschool; Humans; Piperidines; Pyrimidines; Pyrroles | 2022 |
Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.
Topics: Adult; Alopecia; Alopecia Areata; Arabs; Child; Cohort Studies; Female; Humans; Male; Prospective Studies; Pyrroles | 2022 |
Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Folliculitis decalvans responsive to tofacitinib: A case series.
Topics: Alopecia; Folliculitis; Humans; Piperidines; Pyrimidines; Pyrroles | 2020 |
[Successful treatment of alopecia totalis with tofacitinib in a Danish patient].
Topics: Adult; Alopecia; Denmark; Humans; Male; Piperidines; Pyrimidines; Pyrroles | 2020 |
[Alopecia areata with good response to tofacitinib].
Topics: Alopecia; Alopecia Areata; Female; Humans; Middle Aged; Piperidines; Pyrimidines; Pyrroles | 2021 |
Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alopecia universalis.
Topics: Alopecia; Alopecia Areata; Humans; Minoxidil; Piperidines; Pyrimidines; Pyrroles | 2021 |
Pediatric Game Changers∗: Oral tofacitinib for the treatment of alopecia areata in children.
Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles | 2021 |
Alopecia areata flare patterns in children and young adults while on systemic tofacitinib.
Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles; Young Adult | 2022 |
Topical tofacitinib for the treatment of alopecia areata affecting facial hair.
Topics: Administration, Topical; Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles | 2021 |
Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis.
Topics: Administration, Oral; Adolescent; Alopecia; Child; Dermatologic Agents; Humans; Janus Kinase 1; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult | 2017 |
Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment.
Topics: Adult; Alopecia; Female; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome | 2017 |
Image Gallery: Treatment of refractory alopecia universalis with oral tofacitinib citrate and adjunct intralesional triamcinolone injections.
Topics: Administration, Oral; Alopecia; Drug Therapy, Combination; Glucocorticoids; Humans; Injections, Intralesional; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Triamcinolone; Young Adult | 2017 |
Excellent response to tofacitinib treatment in a patient with alopecia universalis.
Topics: Alopecia; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult | 2017 |
Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Topics: Administration, Topical; Alopecia; Animals; Hair; Janus Kinase 3; Male; Mice; Mice, Inbred C57BL; Minoxidil; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Vascular Endothelial Growth Factor A | 2017 |
Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.
Topics: Adult; Alopecia; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Indoles; Kidney Neoplasms; Krukenberg Tumor; Peritoneal Neoplasms; Pyrroles; Sunitinib; Treatment Outcome; Young Adult | 2018 |
Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
Topics: Administration, Topical; Adolescent; Alopecia; Alopecia Areata; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hair; Humans; Male; Pediatrics; Piperidines; Pyrimidines; Pyrroles; Sampling Studies; Treatment Outcome | 2018 |
Tofacitinib for the treatment of lichen planopilaris: A case series.
Topics: Administration, Oral; Adult; Aged; Alopecia; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Lichen Planus; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Retrospective Studies; Scalp; Scalp Dermatoses; Skin; Time Factors; Treatment Outcome | 2018 |
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Cyclopropanes; Cyclosporine; Female; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2019 |
Tofacitinib therapy for children with severe alopecia areata.
Topics: Alopecia; Alopecia Areata; Child, Preschool; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index | 2019 |
Alopecia universalis. Partial response to tofacitinib.
Topics: Adult; Alopecia; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2019 |
An urticarial drug eruption caused by tofacitinib for alopecia universalis.
Topics: Alopecia; Drug Eruptions; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Urticaria; Young Adult | 2019 |
Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.
Topics: Adult; Alopecia; Dose-Response Relationship, Drug; Humans; Male; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Treatment Outcome | 2014 |
Two birds that exclude each other: the Renbök phenomenon.
Topics: Alopecia; Humans; Male; Piperidines; Psoriasis; Pyrimidines; Pyrroles | 2015 |
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.
Topics: Adult; Alopecia; Female; Humans; Janus Kinases; Male; Nail Diseases; Nails; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2016 |
Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
Topics: Adult; Alopecia; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome | 2016 |
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Topics: Adolescent; Alopecia; Alopecia Areata; Arthritis, Psoriatic; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retreatment | 2017 |
Tofacitinib for the treatment of alopecia areata and variants in adolescents.
Topics: Adolescent; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2017 |
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
Topics: Adolescent; Adult; Aged; Alopecia; Alopecia Areata; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Reversal of Alopecia Universalis by Tofacitinib: A Case Report.
Topics: Adult; Alopecia; Female; Humans; Janus Kinase 1; Janus Kinase 3; Janus Kinase Inhibitors; Male; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult | 2016 |
Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.
Topics: Adult; Alopecia; Female; Humans; Male; Nail Diseases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome | 2017 |
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult | 2009 |
Alopecia associated with atorvastatin.
Topics: Adult; Alopecia; Atorvastatin; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrroles; Risk Assessment | 2002 |